Literature DB >> 8136043

Noradrenergic and cholinergic interactions in the amygdala and the modulation of memory storage.

C Dalmaz1, I B Introini-Collison, J L McGaugh.   

Abstract

Numerous studies have reported that, in rats, memory can be affected by manipulations of the amygdala noradrenergic system. Typically, low doses of norepinephrine facilitate while higher doses impair memory storage. Muscarinic cholinergic agonists facilitate, while antagonists impair memory storage. Recent evidence from studies using systemic injection of drugs, indicates that these two systems interact in modulating memory storage. The experiments reported here examined interactions between the amygdala noradrenergic and muscarinic cholinergic systems. The results indicate that activation of muscarinic cholinergic mechanisms in the amygdala enhances retention, and that such activation mediates the facilitatory effects of systemically administered oxotremorine. beta-Noradrenergic agonists appear to exert their effects in the amygdala by activating the release of acetylcholine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8136043     DOI: 10.1016/0166-4328(93)90101-u

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  16 in total

Review 1.  Functional activities of the amygdala: an overview.

Authors:  A A Rasia-Filho; R G Londero; M Achaval
Journal:  J Psychiatry Neurosci       Date:  2000-01       Impact factor: 6.186

2.  Enhancement of inhibitory avoidance and conditioned taste aversion memory with insular cortex infusions of 8-Br-cAMP: involvement of the basolateral amygdala.

Authors:  María I Miranda; James L McGaugh
Journal:  Learn Mem       Date:  2004 May-Jun       Impact factor: 2.460

3.  Effects of the beta-blocker propranolol on cued and contextual fear conditioning in humans.

Authors:  Christian Grillon; Jeremy Cordova; Charles Andrew Morgan; Dennis S Charney; Michael Davis
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

4.  Bone morphogenetic protein signaling in the developing telencephalon controls formation of the hippocampal dentate gyrus and modifies fear-related behavior.

Authors:  Giuliana Caronia; Jennifer Wilcoxon; Polina Feldman; Elizabeth A Grove
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 5.  Drug enhancement of memory consolidation: historical perspective and neurobiological implications.

Authors:  James L McGaugh; Benno Roozendaal
Journal:  Psychopharmacology (Berl)       Date:  2008-08-15       Impact factor: 4.530

6.  Basolateral amygdala noradrenergic influence enables enhancement of memory consolidation induced by hippocampal glucocorticoid receptor activation.

Authors:  B Roozendaal; B T Nguyen; A E Power; J L McGaugh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 7.  Pharmacological enhancement of fear reduction: preclinical models.

Authors:  Bronwyn M Graham; Julia M Langton; Rick Richardson
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 8.  Memory modulation.

Authors:  Benno Roozendaal; James L McGaugh
Journal:  Behav Neurosci       Date:  2011-12       Impact factor: 1.912

9.  Involvement of basolateral amygdala GABAA receptors in the effect of dexamethasone on memory in rats.

Authors:  Lotfollah Khajehpour; Acieh Alizadeh-Makvandi; Mahnaz Kesmati; Hooman Eshagh-Harooni
Journal:  J Zhejiang Univ Sci B       Date:  2011-11       Impact factor: 3.066

10.  Involvement of the basolateral amygdala in muscarinic cholinergic modulation of extinction memory consolidation.

Authors:  Mariano M Boccia; Mariano G Blake; Carlos M Baratti; James L McGaugh
Journal:  Neurobiol Learn Mem       Date:  2008-09-03       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.